Uncategorized

Advita Ortho was formed after orthopedic implant maker Exactech sold its assets in bankruptcy.

IT developers who lose their certification would also forfeit some financial incentives, ASTP/ONC head Dr. Thomas Keane said at the HIMSS conference.

  Aunque parece que el Bitcoin es algo novedoso, lo cierto es que ya lleva entre nosotros 17 años. Pese a ello, es un activo financiero que pocas personas comprenden.   Siempre se suele decir que es una moneda digital o que se trata de un sistema descentralizado, pero nadie sab …

The technology giant is the latest in a string of companies to roll out an AI tool specific to consumers’ health queries.

Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could alter the drug’s toxicity profile and pose safety risks to patients, the company said in an open letter.

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies for spinal muscular atrophy, Duchenne muscular dystrophy and Becker muscular dystrophy.

Data from BridgeBio Pharma’s Phase 3 FORTIFY study show that BBP-418 significantly increases levels of a key disease biomarker that helps stabilize muscles in patients with limb-girdle muscular dystrophy.

The chief executives of AbbVie and Johnson & Johnson are now among the highest-paid pharma leaders after pay bumps pushed their 2025 compensations past $30 million.

Tradicionalmente, la habitabilidad se ha vinculado a la presencia estable de agua líquida, lo que ha llevado a considerar que la superficie actual de Marte, un desierto hiperárido, es demasiado seca para albergar vida activa hoy en día. Sin embargo, un reciente estudio internaci …

In this episode of Denatured, you’ll listen to Oxana Iliach, senior director of regulatory strategy at Certara and Vera Pomerantseva, director of product management for risk-based quality management at eClinical Solutions. We speak about how the FDA’s latest decision to have one, rather than two pivotal studies, for new drug applications raises the bar for